Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 11—November 2009

Research

Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003

Toby LeslieComments to Author , Harpakash Kaur, Nasir Mohammed, Kate Kolaczinski, Rosalynn L. Ord, and Mark Rowland
Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (T. Leslie, H. Kaur, K. Kolaczinski, R.L. Ord, M. Rowland); HealthNet TPO, Kabul, Afghanistan (T. Leslie, N. Mohammed)

Main Article

Table 3

Frequency of treatment failure for infection with Plasmodium falciparum or P. vivax, by group, sex, and age, Pakistan, October 2003*

Characteristic Failure rate (%) Crude OR (95% CI) Adjusted OR (95% CI)
Group
Comparison group 4/40 (10.0) 1 1
Ashgaroo
43/151 (28.5)
3.6 (1.2–10.7)
3.2 (1.0–10.1)
Sex
M 27/90 (30.0) 1 1
F
20/99 (20.2)†
0.6 (0.3–1.2)
0.5 (0.3–1.2)
Age group, y
0–5 16/40 (40.0) 1 1
6–10 21/72 (29.2) 0.6 (0.3–1.4) 0.6 (0.3–1.1)
11–20 4/33 (12.2) 0.2 (0.1–0.7) 0.3 (0.1–1.0)
>20 6/46 (13.0) 0.2 (0.1–0.6) 0.3 (0.1–0.8)

*OR, odds ratio; CI, confidence interval.
†Results exclude losses to follow-up.

Main Article

TOP